KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Liabilities and Shareholders Equity (2016 - 2025)

Maxlinear (MXL) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $796.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 7.89% to $796.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.3 billion, a 11.7% decrease, with the full-year FY2025 number at $796.4 million, down 7.89% from a year prior.
  • Liabilities and Shareholders Equity was $796.4 million for Q4 2025 at Maxlinear, down from $808.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.2 billion in Q1 2023 to a low of $796.4 million in Q4 2025.
  • A 5-year average of $1.0 billion and a median of $1.1 billion in 2021 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 48.13% in 2021, then fell 19.96% in 2024.
  • Maxlinear's Liabilities and Shareholders Equity stood at $1.1 billion in 2021, then increased by 12.34% to $1.2 billion in 2022, then dropped by 8.45% to $1.1 billion in 2023, then dropped by 19.96% to $864.6 million in 2024, then dropped by 7.89% to $796.4 million in 2025.
  • Per Business Quant, the three most recent readings for MXL's Liabilities and Shareholders Equity are $796.4 million (Q4 2025), $808.1 million (Q3 2025), and $863.7 million (Q2 2025).